TGA Of Australia Probes Adverse Flu-Vaccine Effects In Youngest Kids
This article was originally published in PharmAsia News
Australia's Therapeutic Goods Administration has launched a probe into whether the seasonal flu vaccine is safe for children under five years of age. The nation's chief medical officer advised physicians to cease giving the shots to children in that age group after seeing a sharp increase in adverse reactions in West Australia. The reports said the young children often experienced fever and convulsions in response to the inoculations. The vaccine was made by Australia's CSL, which has been asked by authorities to identify the batches sent to the Australian state and to test them. (Click here for more
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.